GlassScriptPhysician profile
Ralph B Breslaw
NPI 1366459430
$15,103.79
in general payments reported to CMS, 2019-2025
13 companies · $1,782 in 2025
The $1,782 reported for 2025 was more than what 80% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $266 · 2020: $18.79 · 2021: $12K · 2022: $142 · 2023: $220 · 2024: $501 · 2025: $1,782.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,780 · Travel and Lodging: $723.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,780.18 |
| Travel and Lodging | $722.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $13,616.54 | 2019-2025 | Da Vinci Surgical System |
| Medtronic, INC. | $848.29 | 2021-2025 | Ligasure, Maxtack, Transorb |
| Kerecis Limited | $214.00 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Merck Sharp & Dohme LLC | $114.52 | 2019 | |
| Integra Lifesciences Corporation | $65.24 | 2021-2024 | Integra, Omnigraft, Integra Dermal Regeneration Template |
| Davol INC. | $65.01 | 2019-2020 | |
| Csl Behring | $45.91 | 2023 | Kcentra |
| Asensus Surgical, INC. | $42.96 | 2019 | |
| Ethicon US, LLC | $25.68 | 2023 | Echelon Flex |
| Heron Therapeutics, INC. | $20.27 | 2021 | |
| Shire North American Group INC | $17.51 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $15.27 | 2024 | Exparel |
| Stryker Corporation | $12.59 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ralph Breslaw listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.